This dataset consists of 620 sample and QC SELDI spectra
used in Pusztai et al,
"Pharmacoproteomic Analysis of Prechemotherapy and Postchemotherapy
Plasma Samples from Patients Receiving Neoadjuvant or Adjuvant
Chemotherapy for Breast Carcinoma",
Cancer 2004;100:1814-22.
Summary of Study: Proteomic changes in NAF plasma were taken
before and after paclitaxel or FAC (5-fluorouracil, doxorubicin,
and cyclophosphamide) chemotherapy in patients with Stage I - III
breast carcinoma to measure response to the chemotherapy. Samples
of healthy women were taken also, to help identify breast
carcinoma-associated protein markers.
Full Abstract
All of the SELDI spectra have been exported as XML files using version 3.1.1 of the Ciphergen software. Further details are supplied in the README file.
README (13K text)
Clinical Information (13K zip file)
March03 Low Mass Scans (52.8M zip file)
March03 High Mass Scans (56.3M zip file)
June03 Low Mass Scans (47.2M zip file)
June03 High Mass Scans (52.8M zip file)
Back to MDACC Bioinformatics